Prof. Dr. med Stefan Endres

Direktor der Abteilung für Klinische Pharmakologie, Forschungsdekan der Medizinischen Fakultät

Adress: Division of Clinical Pharmacology
Department of Medicine IV
Klinikum der Ludwig-Maximilians-Universität München
Lindwurstrasse 2a
D-80337 München
Room: K1.19
Phone: 089/ 4400-5 7300
Fax: 089/4400-5 7330
E-Mail: endres@lmu.de
Publications: Endres S

stefan_endres

 

Academic Education and degrees

 

1967 - 1975 Secondary School Gymnasium bei St. Anna (humanistic, modern languages), Augsburg; skipping grade 10.
1974 Second Prize in German Federal Mathematics Competition (Bundeswettwerb Mathematik)
1975 Entering Medical School at Ludwig-Maximilians- Universität, Munich
1977 - 1979 Two years study at Harvard University, Cambridge, Massachusetts
1979 Bachelor of Arts degree with magna cum laude, Department of Biochemistry and Immunology, Harvard University
1982 Core clinical clerkship Internal Medicine at Beth Israel Hospital, Harvard Medical School, Boston
1983 State Medical Boards, Munich
1984 M.D. degree with magna cum laude, Ludwig-Maximilians- Universität, Munich, Germany

 

Academic positions

 

1997 - Full Professor of Clinical Pharmacology, Director, Division of Clinical Pharmacology, Ludwig-Maximilian University
1997 - Member of Committee on Drug Evaluation (Arzneimittelkommission)
1997 - 2004 Course Director teaching program of Harvard Educational Alliance
1998 - 2009 Chairman, Subcommittee on Drugs in Gastrointestinal Disease
2002 - Member of the Faculty Council (Fachbereichsrat), Medical Faculty, LMU
2003 - 2007 Principal Investigator of investigator-intitated phase II study with autologous
2003 - Member of the Ethics Committee (Bayerische Landesärztekammer) dendritic cell vaccination for patients with pancreatic cancer
2005 - 2006 Member of the Board (Vorstand) of Ludwig-Maximilian University Clinics
2006 - Consultant for biotech companies designing phase II studies for immunotherapy of patients with autoimmune or infectious diseases
2006 - Board of Directors (Aufsichtsrat) of Ludwig-Maximilian University Clinics for five more years (2009 annual budget: 845 million Euro; 9,929 employees)
2007 - 2012 Member of the Board of the Clinical Study Center, newly established to coordinate clinical studies at the Ludwig-Maximilian University
2007 - 2012 LMUexcellent Research Professor as one out of eleven grantees
2007 - Principal investigator in the excellence cluster Center of Integrated Protein Science Munich (CIPS-M)
2007 - Dean of Research, Medical Faculty, Ludwig-Maximilian University; reelection for terms 2010 to 2013 and 2013 to 2016 (2013 budget for research and education: 148 million Euro); excellence university in the German excellence initiative
2007 - Chairman of the newly formed Research Committee of the Medical Faculty
2009 - 2015 Spokesman of the DFG Graduate Research Centre GK 1202 “Oligonucleoti- des in cell biology and therapy” (renewal with 3,535,078 Euro funding until 2015)
2011 Appointment as Jury Member for European Research Council (ERC), Selection Jury Advanced Investigator Grant, Panel Immunology and Infection
2011 Appointment as Visiting Professor Harvard Medical School, Division of Immunology (Laboratory Prof. von Andrian), April to August 2011
2011 - Board of Directors (Aufsichtsrat), reelected for term 2011 to 2016
2011 - Member of Scientific Advisory Committee, Vaccine and Immunotherapy Center (VIC), Massachusetts General Hospital, Harvard University, Boston
2012 Member of search committee for chief of medicine (Ärztlicher Direktor) of Ludwig-Maximilian University Clinics
2012 - Area coordinator (Area D Protein nucleic acid interactions) and PI, excellence cluster Center of Integrated Protein Science (CIPS-M), 2012 to 2017
2013 - Member of the Scientific Board (Wissenschaftskommission) of the Else Kröner Fresenius-Stiftung; since 2015 Deputy Chairman
2013 - Scientific advisor for the Paul Martini-Stiftung
2014 - Speaker of newly established International Doctoral Program “i-Target: Immuntargeting of Cancer”, funded by Elite Network of Bavaria (2014 to 2018)
2015 - Speaker of newly established Marie-Sklodowska-Curie training network “Immutrain: Immunotherapy of Cancer”, funded by Horizon 2020 (2015 to 2018)
2016 - German Cancer Consortium (DKTK); Member of local steering committee; Partner site Munich

 

Additional professional functions

 

1984 -1987 Medical Internship at Medizinische Klinik Innenstadt, Ludwig-Maximilians- Universität München (Director: Prof. Dr. P. C. Scriba)
1987 - 1988 Member of Committee on Drug Evaluation (Arzneimittelkommission)
1988 -1997 Residency, Subspecialty Fellowship and Research Group Leader at Medizinische Klinik Innenstadt, Ludwig-Maximilians- Universität
1991 Specialty boards Internal Medicine
1992 Habilitation for Internal Medicine (Assistant Professor)
1993 Subspeciality boards Intensive Care Medicine, Attending Physician at the Department of Internal Medicine
1996 Subspeciality boards Gastroenterology, senior physician at intensive care unit
2003 Board-certified Immunologist (German Society of Immunology)